The results of our study and previous researches demonstrated that TLR3 was closely related to the tumor immune microenvironment (Zou et al., 2022), and this study provided an explanation for the different prognostic outcome of TLR3 in different cancers. The gene discussed is TLR3; the disease is cancer.